Foods rich in cocoa appear to reduce blood pressure but drinking tea may not, according to an analysis of previously published research in the April 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
A new study published in the Journal of the American Medical Association found no increased risk of heart attack for women in their 50s who were taking HRT.
The U.S. Food and Drug Administration (FDA) announced the approval of HepaGam B for the prevention of hepatitis B reinfection in certain liver transplant patients. HepaGam B is the first product of its kind (an immune globulin product) approved for this purpose.
The U.S. Food and Drug Administration (FDA) announced the approval of HepaGam B for the prevention of hepatitis B reinfection in certain liver transplant patients.
Binghamton University Professor Gary D. James is hoping his new book will take the stress out of researching stress. Offering guidance on topics ranging from the best ways to collect saliva and urine to working with special populations including pregnant women and the elderly, James expects that the book will help students and professionals design more effective field studies and models for stress measurement.
Endoscopic variceal ligation is cost-effective relative to beta-blockers for the prevention of variceal bleeding in cirrhotic patients if quality of life-years are considered. If only life-years are considered, then endoscopic variceal ligation is not cost-effective.
The lack of health insurance prompts people to forego routine physical exams and have a reduced awareness of cardiovascular risk factors and is associated with increased rates of stroke and death, researchers have concluded.
New genetic markers may be able to predict whether a person is likely to have coronary heart disease (CAD) in the future.
Diabetes and high blood pressure, two conditions rooted in genetics and environmental surroundings, play a much greater role than race alone in determining who is mostly likely to develop heart failure, according to the latest study from cardiologists at Johns Hopkins. Each year, nearly 300,000 Americans die from heart failure.
Researchers today reported that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiology?s 56th Annual Scientific Session.